Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1924)
All Articles published online
|
Jun 28, 2005 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guan YS, Liu Y, Sun L, Li X, He Q. Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization. World J Gastroenterol 2005; 11(24): 3803-3805 [PMID: 15968745 DOI: 10.3748/wjg.v11.i24.3803] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i24/3803.htm |
| Number | Citing Articles |
| 1 |
Wei-Wei Zhang, Longjiang Li, Dinggang Li, Jiliang Liu, Xiuqin Li, Wei Li, Xiaolong Xu, Michael J. Zhang, Lois A. Chandler, Hong Lin, Aiguo Hu, Wei Xu, Dominic Man-Kit Lam. The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the Clinic. Human Gene Therapy 2018; 29(2): 160 doi: 10.1089/hum.2017.218
|
| 2 |
Shao Wen Xiao, Yi-Zhi Xu, Bu-Fan Xiao, Jing Jiang, Chang-Qing Liu, Zhi-wei Fang, Dong-Ming Li, Xiao Fan Li, Yong Cai, Yong Heng Li, Yan Sun, Xing Su, Guang-Ying Zhu, Shan Wen Zhang. Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas. Human Gene Therapy 2018; 29(6): 699 doi: 10.1089/hum.2017.103
|
| 3 |
Z R Yang, H F Wang, J Zhao, Y Y Peng, J Wang, B-A Guinn, L Q Huang. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Therapy 2007; 14(7): 599 doi: 10.1038/sj.cgt.7701054
|
| 4 |
Qi Xie, Biling Liang, Jing Zhang, Qihua Yang, Xiongfei Gu, Jing Xu, Mingwang Chen. In vivo comparison of transduction efficiency with recombinant adenovirus-mediated p53 in a human colon cancer mouse model by different delivery routes. The Chinese-German Journal of Clinical Oncology 2008; 7(12): 704 doi: 10.1007/s10330-008-0123-y
|
| 5 |
Ana M. Almeida, João A. Queiroz, Fani Sousa, Ângela Sousa. Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discovery Today 2019; 24(10): 2044 doi: 10.1016/j.drudis.2019.07.011
|
| 6 |
Hiroaki Sawahara, Hidenori Shiraha, Daisuke Uchida, Hironari Kato, Ryo Kato, Atsushi Oyama, Teruya Nagahara, Masaya Iwamuro, Shigeru Horiguchi, Koichiro Tsutsumi, Mari Mandai, Tetsushige Mimura, Nozomu Wada, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Shinichiro Nakamura, Masami Watanabe, Masakiyo Sakaguchi, Akinobu Takaki, Kazuhiro Nouso, Takahito Yagi, Yasutomo Nasu, Hiromi Kumon, Hiroyuki Okada. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf‐3 expressing adenoviral vector for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2017; 32(10): 1769 doi: 10.1111/jgh.13757
|
| 7 |
Qi Xie, Bi-Ling Liang, Yan-Heng Wu, Jing Zhang, Ming-Wang Chen, Hong-Yan Liu, Xiong-Fei Gu, Jin Xu. Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo. Gene 2012; 499(2): 303 doi: 10.1016/j.gene.2012.02.007
|
| 8 |
Astushi Oyama, Hidenori Shiraha, Daisuke Uchida, Masaya Iwamuro, Hironari Kato, Akinobu Takaki, Fusao Ikeda, Hideki Onishi, Tetsuya Yasunaka, Yasuto Takeuchi, Nozomu Wada, Yoshiaki Iwasaki, Masahiro Sakata, Hiroyuki Okada, Hiromi Kumon. A Phase I/Ib trial of Ad-REIC in liver cancer: study protocol. Future Oncology 2019; 15(31): 3547 doi: 10.2217/fon-2019-0115
|
| 9 |
Li Qi, Guiqing Li, Peipei Li, Hongwei Wang, Xiaolong Fang, Tongchuan He, Jingjing Li. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. Genes & Diseases 2024; 11(4): 101155 doi: 10.1016/j.gendis.2023.101155
|
| 10 |
Yosef Buganim, Varda Rotter. p53: Balancing tumour suppression and implications for the clinic. European Journal of Cancer 2009; 45: 217 doi: 10.1016/S0959-8049(09)70037-1
|
| 11 |
Shixi Chen, Jun Chen, Wei Xi, Weidong Xu, Guowen Yin. Clinical Therapeutic Effect and Biological Monitoring of p53 Gene in Advanced Hepatocellular Carcinoma. American Journal of Clinical Oncology 2014; 37(1): 24 doi: 10.1097/COC.0b013e3181fe4688
|